Epigenetic therapy as a novel approach in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Epigenetic therapy as a novel approach in hepatocellular carcinoma

Published:2015-01 Issue: Volume:145 Page:103-119
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Anestopoulos Ioannis,Voulgaridou Georgia Persephoni,Georgakilas Alexandros G.,Franco Rodrigo,Pappa Aglaia,Panayiotidis Mihalis I.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference430 articles.

1. Genomic imprinting: recognition and marking of imprinted loci;Abramowitz;Curr Opin Genet Dev,2012

2. 1,3,4-Tri-O-galloyl-6-O-caffeoyl-β-d-glucopyranose, a new anti-proliferative ellagitannin, regulates the expression of microRNAs in HepG(2) cancer cells;Ai;Nan Fang Yi Ke Da Xue Xue Bao,2011

3. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer;Akiyama;Mol Cell Biol,2003

4. Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy;Amato;Clin Genitourin Cancer,2007

5. The functions of animal microRNAs;Ambros;Nature,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway;International Journal of Oncology;2023-06-22

2. ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner;Science Advances;2022-12-23

3. Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer;Pharmacological Reviews;2022-12-08

4. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12

5. Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma;Journal of Advanced Research;2022-11